Accuracy of Cytologic vs Histologic Specimens for Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Accuracy of Cytologic vs Histologic Specimens for Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer

Published:2023-09 Issue: Volume: Page:
ISSN:0012-3692
Container-title:CHEST
language:en
Short-container-title:CHEST

Author:

Tajarernmuang Pattraporn^ORCID,Aliaga Felipe,Alwakeel Amr J.^ORCID,Tavaziva Gamuchirai,Turner Kimberly^ORCID,Menzies Dick,Wang Hangjun,Ofiara Linda,Benedetti Andrea,Gonzalez Anne V.^ORCID

Funder

Lung Cancer Canada

McGill University

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference62 articles.

1. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway;Ohaegbulam;Trends Mol Med,2015

2. Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms;Ichikawa;Front Biosci,2005

3. PD-L1 expression in advanced NSCLC: insights into risk stratification and treatment selection from a systematic literature review;Brody;Lung Cancer,2017

4. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

5. Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater;Reck;J Clin Oncol,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer;Clinical Lung Cancer;2024-05

2. Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors;Frontiers in Oncology;2024-02-08